Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.
This measurement also informed researchers about the risk of loss of liver function and death in people cured of hepatitis C.
A Mediterranean diet could help reduce the risk of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
The link between COVID-19 and liver disease, along with research about NAFLD and NASH, topped the Hep treatment news this year.
Areas with lower population density have not seen the same slowdown as urban areas.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
Optimal treatment for fatty liver disease may involve combining drugs with different mechanisms of action.
Hepatitis C virus (HCV) is the most common blood-borne virus in the United States.
Over years or decades, hepatitis C can lead to serious complications.
The best-performing combo, firsocostat and cilofexor, showed benefits despite missing the main study endpoint.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
October is Liver Cancer Awareness Month.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
Rates of liver complications were similar, but HIV-positive people had more non-liver cancers and non-liver-related deaths.
Researchers reported significant changes in liver, cardiovascular and diabetes markers.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.